In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 - Takashita, Emi; Yamayoshi, Seiya; Halfmann, Peter; Wilson, Nancy; Ries, Hunter; Richardson, Alex; Bobholz, Max; Vuyk, William; Maddox, Robert; Baker, David A.; Friedrich, Thomas C.; O’Connor, David H.; et al. (The New England journal of medicine, 2022)
Keywords: Antibodies, Viral - immunology; Antiviral agents; Antiviral Agents - immunology; Antiviral Agents - pharmacology; Coronavirus; Coronaviruses; COVID-19 - genetics; COVID-19 - immunology; COVID-19 - virology; COVID-19 vaccines; Disease transmission; Drug dosages; FDA approval; Humans; In Vitro Techniques; Infectious Disease; Infectious diseases; Influenza; Medical research; Monoclonal antibodies; Mutation; Pathogenesis; R&D; Research & development; RNA polymerase; SARS-CoV-2 - drug effects; SARS-CoV-2 - immunology; Severe acute respiratory syndrome coronavirus 2; Vaccine Efficacy; Viral Infections; United States--US; Japan